![Arthur Kirsch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arthur Kirsch
Director/Board Member at
ATEA PHARMACEUTICALS, INC.
Net worth: 4 M $ as of 2026-06-29
Profile
Arthur S.
Kirsch is currently an Independent Director at Liquidia Technologies, Inc. since 2016, an Independent Director at Liquidia Corp.
since 2020, a Director at Anavasi Diagnostics since 2022, an Independent Non-Executive Director at Evommune, Inc. starting in 2025, and an Independent Director at Atea Pharmaceuticals, Inc. starting in 2025.
Former positions include President & Chief Executive Officer at Natwest Securities Corp.
from 1990 to 1993, Chairman at POZEN, Inc. from 2015 to 2016, Independent Chairman at Old API Wind-down Ltd. from 2016 to 2019, Independent Director at Immunomedics, Inc. from 2015 to 2016, Director at PhysioSonics, Inc., Independent Director at Kadmon Holdings, Inc. from 2019 to 2021, Executive Vice President & Head-Equity Division at Drexel Burnham Lambert, Inc. from 1979 to 1990, President at NatWest Securities Ltd. from 1990 to 1993, Executive Vice President & Head-Research at Vector Securities LLC from 1994 to 2004, and MD, Head-Healthcare Research & Capital Markets at Prudential Vector Healthcare Group from 1999 to 2001.
Education includes undergraduate studies at the University of Rhode Island and an MBA from Baruch College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0.05% | 2026-06-15 | 46,637 ( 0.05% ) | 4 M $ | 2026-06-29 |
| 2026-06-17 | 45,710 ( 0.06% ) | 212 552 $ | 2026-06-29 | |
EVOMMUNE, INC. 0.03% | 2026-07-06 | 10,000 ( 0.03% ) | 132 900 $ | 2026-06-29 |
Arthur Kirsch active positions
| Companies | Position | Start |
|---|---|---|
| LIQUIDIA CORPORATION | Director/Board Member | 2020-06-27 |
| ATEA PHARMACEUTICALS, INC. | Director/Board Member | 2025-02-19 |
| EVOMMUNE, INC. | Director/Board Member | 2025-11-06 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Director/Board Member | 2016-12-12 |
Anavasi Diagnostics
 Anavasi Diagnostics Medical SpecialtiesHealth Technology Operates as a medical technology company that develops molecular diagnostic testing | Director/Board Member | 2022-11-01 |
Former positions of Arthur Kirsch
| Companies | Position | End |
|---|---|---|
| KADMON HOLDINGS, INC. | Director/Board Member | 2021-10-31 |
| OLD API WIND-DOWN LTD. | Chairman | 2019-05-29 |
| IMMUNOMEDICS, INC. | Director/Board Member | 2016-10-12 |
| POZEN INC. | Chairman | 2016-02-04 |
| ░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Arthur Kirsch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops therapeutics for diseases | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
PhysioSonics, Inc.
 PhysioSonics, Inc. Medical DistributorsDistribution Services Develops neurological medical devices | Distribution Services |
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
Drexel Burnham Lambert, Inc.
 Drexel Burnham Lambert, Inc. Agricultural Commodities/MillingProcess Industries Manufactures chocolates and sugar candies. | Process Industries |
NatWest Securities Ltd.
 NatWest Securities Ltd. Investment Banks/BrokersFinance Security Brokers Dealers | Finance |
University of Rhode Island
 University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vector Securities LLC
 Vector Securities LLC Investment Banks/BrokersFinance Provides investment banking services | Finance |
Baruch College
 Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Natwest Securities Corp. | |
Prudential Vector Healthcare Group
 Prudential Vector Healthcare Group Investment ManagersFinance Provides investment banking services | Finance |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
Anavasi Diagnostics
Anavasi Diagnostics Medical SpecialtiesHealth Technology Operates as a medical technology company that develops molecular diagnostic testing | Health Technology |
- Stock Market
- Insiders
- Arthur Kirsch
